annual accounts payable:
$16.19M-$1.35M(-7.70%)Summary
- As of today (May 18, 2025), ACAD annual accounts payable is $16.19 million, with the most recent change of -$1.35 million (-7.70%) on December 31, 2024.
- During the last 3 years, ACAD annual accounts payable has risen by +$9.32 million (+135.49%).
- ACAD annual accounts payable is now -7.70% below its all-time high of $17.54 million, reached on December 31, 2023.
Performance
ACAD Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$18.09M+$1.90M(+11.75%)Summary
- As of today (May 18, 2025), ACAD quarterly accounts payable is $18.09 million, with the most recent change of +$1.90 million (+11.75%) on March 31, 2025.
- Over the past year, ACAD quarterly accounts payable has dropped by -$1.24 million (-6.40%).
- ACAD quarterly accounts payable is now -8.99% below its all-time high of $19.88 million, reached on June 30, 2024.
Performance
ACAD quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ACAD Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.7% | -6.4% |
| 3 y3 years | +135.5% | +68.0% |
| 5 y5 years | +124.2% | +173.2% |
ACAD Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.7% | +135.5% | -9.0% | +80.8% |
| 5 y | 5-year | -7.7% | +135.5% | -9.0% | +421.3% |
| alltime | all time | -7.7% | +4252.7% | -9.0% | +4764.3% |
ACAD Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $18.09M(+11.8%) |
| Dec 2024 | $16.19M(-7.7%) | $16.19M(-15.1%) |
| Sep 2024 | - | $19.08M(-4.0%) |
| Jun 2024 | - | $19.88M(+2.8%) |
| Mar 2024 | - | $19.33M(+10.2%) |
| Dec 2023 | $17.54M(+37.6%) | $17.54M(+42.5%) |
| Sep 2023 | - | $12.31M(-34.6%) |
| Jun 2023 | - | $18.81M(+8.0%) |
| Mar 2023 | - | $17.42M(+36.7%) |
| Dec 2022 | $12.75M(+85.4%) | $12.75M(+27.4%) |
| Sep 2022 | - | $10.01M(-15.6%) |
| Jun 2022 | - | $11.85M(+10.1%) |
| Mar 2022 | - | $10.77M(+56.6%) |
| Dec 2021 | $6.88M(-19.0%) | $6.88M(-11.0%) |
| Sep 2021 | - | $7.72M(-14.8%) |
| Jun 2021 | - | $9.06M(+2.4%) |
| Mar 2021 | - | $8.85M(+4.2%) |
| Dec 2020 | $8.49M(+17.6%) | $8.49M(+144.7%) |
| Sep 2020 | - | $3.47M(-46.3%) |
| Jun 2020 | - | $6.47M(-2.4%) |
| Mar 2020 | - | $6.62M(-8.3%) |
| Dec 2019 | $7.22M(+128.0%) | $7.22M(+109.7%) |
| Sep 2019 | - | $3.44M(-25.9%) |
| Jun 2019 | - | $4.65M(+42.0%) |
| Mar 2019 | - | $3.27M(+3.4%) |
| Dec 2018 | $3.17M(-64.0%) | $3.17M(+7.2%) |
| Sep 2018 | - | $2.96M(-11.3%) |
| Jun 2018 | - | $3.33M(+11.2%) |
| Mar 2018 | - | $3.00M(-65.9%) |
| Dec 2017 | $8.79M(+124.6%) | $8.79M(+196.6%) |
| Sep 2017 | - | $2.96M(-17.4%) |
| Jun 2017 | - | $3.59M(+65.7%) |
| Mar 2017 | - | $2.17M(-44.6%) |
| Dec 2016 | $3.91M(+134.0%) | $3.91M(+38.3%) |
| Sep 2016 | - | $2.83M(+176.2%) |
| Jun 2016 | - | $1.02M(-21.7%) |
| Mar 2016 | - | $1.31M(-21.8%) |
| Dec 2015 | $1.67M(-17.1%) | $1.67M(-24.1%) |
| Sep 2015 | - | $2.20M(-24.4%) |
| Jun 2015 | - | $2.92M(+15.8%) |
| Mar 2015 | - | $2.52M(+24.9%) |
| Dec 2014 | $2.02M | $2.02M(+81.6%) |
| Sep 2014 | - | $1.11M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $1.10M(-29.3%) |
| Mar 2014 | - | $1.56M(+319.9%) |
| Dec 2013 | $372.00K(-72.9%) | $372.00K(-66.8%) |
| Sep 2013 | - | $1.12M(-4.8%) |
| Jun 2013 | - | $1.18M(-15.7%) |
| Mar 2013 | - | $1.40M(+1.5%) |
| Dec 2012 | $1.38M(-29.8%) | $1.38M(+21.6%) |
| Sep 2012 | - | $1.13M(+49.4%) |
| Jun 2012 | - | $757.00K(-26.9%) |
| Mar 2012 | - | $1.03M(-47.2%) |
| Dec 2011 | $1.96M(-0.6%) | $1.96M(+55.3%) |
| Sep 2011 | - | $1.26M(+10.8%) |
| Jun 2011 | - | $1.14M(-17.5%) |
| Mar 2011 | - | $1.38M(-30.0%) |
| Dec 2010 | $1.97M(-33.1%) | $1.97M(-24.6%) |
| Sep 2010 | - | $2.62M(+13.8%) |
| Jun 2010 | - | $2.30M(+8.4%) |
| Mar 2010 | - | $2.12M(-28.0%) |
| Dec 2009 | $2.95M(+29.1%) | $2.95M(+15.4%) |
| Sep 2009 | - | $2.55M(-35.8%) |
| Jun 2009 | - | $3.98M(-4.9%) |
| Mar 2009 | - | $4.18M(+83.3%) |
| Dec 2008 | $2.28M(-11.9%) | $2.28M(-6.8%) |
| Sep 2008 | - | $2.45M(-23.8%) |
| Jun 2008 | - | $3.22M(+57.2%) |
| Mar 2008 | - | $2.05M(-21.0%) |
| Dec 2007 | $2.59M(-23.5%) | $2.59M(-12.2%) |
| Sep 2007 | - | $2.95M(+29.8%) |
| Jun 2007 | - | $2.27M(-25.7%) |
| Mar 2007 | - | $3.06M(-9.7%) |
| Dec 2006 | $3.39M(+63.4%) | $3.39M(+5.6%) |
| Sep 2006 | - | $3.21M(-6.2%) |
| Jun 2006 | - | $3.42M(+366.4%) |
| Mar 2006 | - | $733.00K(-64.6%) |
| Dec 2005 | $2.07M(-3.7%) | $2.07M(+19.9%) |
| Sep 2005 | - | $1.73M(-25.4%) |
| Jun 2005 | - | $2.32M(+70.8%) |
| Mar 2005 | - | $1.36M(-37.0%) |
| Dec 2004 | $2.15M(+40.5%) | $2.15M(-12.1%) |
| Sep 2004 | - | $2.45M(+23.5%) |
| Jun 2004 | - | $1.98M(-21.6%) |
| Mar 2004 | - | $2.53M(+65.1%) |
| Dec 2003 | $1.53M(+36.8%) | $1.53M |
| Dec 2002 | $1.12M | - |
FAQ
- What is ACADIA Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual accounts payable year-on-year change?
- What is ACADIA Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly accounts payable year-on-year change?
What is ACADIA Pharmaceuticals annual accounts payable?
The current annual accounts payable of ACAD is $16.19M
What is the all time high annual accounts payable for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual accounts payable is $17.54M
What is ACADIA Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ACAD annual accounts payable has changed by -$1.35M (-7.70%)
What is ACADIA Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ACAD is $18.09M
What is the all time high quarterly accounts payable for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly accounts payable is $19.88M
What is ACADIA Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ACAD quarterly accounts payable has changed by -$1.24M (-6.40%)